How Anti‐Idiotypic Antibodies Can Aid the Generation of Antibody Drugs
The development of robust assays for the assessment of biotherapeutic immunogenicity and drug availability depends on highly reliable detection reagents. Recombinant anti‐idiotypic antibodies can provide a robust and dependable way to monitor your antibody drug candidate through pharmacokinetic (PK) and anti‐drug antibody (ADA) assays.
Read this article to learn:
- Why anti‐idiotypic antibodies are recognized as optimal detection reagents for use in PK and ADA assays
- What the different binding types and properties of anti‐idiotypic antibodies are
- How recombinant antibody technology can provide you with a secure long term supply of fully‐human antibodies
Download the Article
Share a little information with us to access the entire article now.
Thank you for your interest!
Your download is ready.Download PDF
Overcome the Challenges of PK Assay Development Using Custom Antibodies
Learn how the generation of anti‐idiotypic antibodies and other high specificity tool antibody critical reagents are made to support PK assay design.
Maximizing Screening Speed and Throughput with Flow Cytometry
This infographic highlights challenges for high‐throughput flow cytometry and how the ZE5 Cell Analyzer has solutions to overcome them.